Introduction Some of the fungi have become pathogenic to humans, and these opportunistic
pathogens are able to cause severe systemic mycoses. Areas covered The number of …

Due to their eukaryotic heritage, the differences between a fungal pathogen's molecular
makeup and its human host are small. Therefore, the discovery and subsequent …

In recent years, incidences of invasive fungal infections have greatly increased, especially in
immunosuppressed patients, but most today's antifungal drugs are not completely effective …

Invasive fungal infections are a serious threat to public health, particularly to people with
compromised or suppressed immunity. Although the current antifungal therapies have been …

Recent investigations have yielded both profound insights into the mechanisms required by
pathogenic fungi for virulence within the human host, as well as novel potential targets for …

Promising new compounds have recently been identified in an effort to supplement the
relatively sparse portfolio of antifungal drugs. Many of these compounds have defined …

The need for better antifungal therapy is commonly accepted in view of the high mortality
rates associated with systemic infections, the low number of available antifungal classes …

Undoubtedly, innovative research efforts will continue in the 21 st century as we seek to
minimize the incidence of opportunistic fungal infections worldwide, exploit available and …

Introduction: Superficial infections involving the skin and mucosa are the most common
fungal disease in humans. Fungi can also produce invasive infections (IFI), which are …

The current review issue regarding'Fungal Infections and Antifungal Strategies' unites
reviews regarding (i) the infection process of pathogenic fungi resulting in topical or systemic …